AAAAAA
Results: 1-25/28
Authors:
MEROPOL NJ
Citation: Nj. Meropol, ORAL FLUOROPYRIMIDINES IN THE TREATMENT OF COLORECTAL-CANCER, European journal of cancer, 34(10), 1998, pp. 1509-1513
Authors:
BUDMAN DR
MEROPOL NJ
REIGNER B
CREAVEN PJ
LICHTMAN SM
BERGHORN E
BEHR J
GORDON RJ
OSTERWALDER B
GRIFFIN T
Citation: Dr. Budman et al., PRELIMINARY STUDIES OF A NOVEL ORAL FLUOROPYRIMIDINE CARBAMATE - CAPECITABINE, Journal of clinical oncology, 16(5), 1998, pp. 1795-1802
Authors:
MEROPOL NJ
WOOD DE
NEMUNAITIS J
PETRELLI NJ
LIPMAN BJ
AGOSTI JM
WHITMORE JB
Citation: Nj. Meropol et al., RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN ONCOLOGICSURGERY, Journal of clinical oncology, 16(3), 1998, pp. 1167-1173
Authors:
CREAVEN PJ
PENDYALA L
MEROPOL NJ
CLENDENINN NJ
WU EY
LOEWEN GM
PROEFROCK A
JOHNSTON A
DIXON M
Citation: Pj. Creaven et al., INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 167-170
Authors:
MEROPOL NJ
BARRESI GM
FEHNIGER TA
HITT J
FRANKLIN M
CALIGIURI MA
Citation: Nj. Meropol et al., EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING, Cancer immunology and immunotherapy, 46(6), 1998, pp. 318-326
Authors:
MEROPOL NJ
BLUMENSON LE
CREAVEN PJ
Citation: Nj. Meropol et al., OCTREOTIDE DOES NOT PREVENT DIARRHEA IN PATIENTS TREATED WITH WEEKLY 5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN, American journal of clinical oncology, 21(2), 1998, pp. 135-138
Authors:
GASKIN DJ
KONG J
MEROPOL NJ
YABROFF KR
WEAVER C
SCHULMAN KA
Citation: Dj. Gaskin et al., TREATMENT CHOICES BY SERIOUSLY ILL PATIENTS - THE HEALTH STOCK RISK ADJUSTMENT MODEL, Medical decision making, 18(1), 1998, pp. 84-94
Authors:
SONI N
MEROPOL NJ
PENDYALA L
NOEL D
SCHACTER LP
GUNTON KE
CREAVEN PJ
Citation: N. Soni et al., PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE BY PROTRACTED VENOUS INFUSION IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(2), 1997, pp. 766-772
Authors:
VAUGHN DJ
MEROPOL NJ
HOLROYDE C
MINTZER D
NUAMAH I
ARMSTEAD B
DOUGLASS HO
HALLER DG
Citation: Dj. Vaughn et al., A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN, ADRIAMYCIN, AND CISPLATIN (FLAP) FOR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA - A PENN CANCER CLINICAL-TRIAL GROUP AND ROSWELL PARK CANCERINSTITUTE COMMUNITY ONCOLOGY RESEARCH-PROGRAM TRIAL, American journal of clinical oncology, 20(3), 1997, pp. 242-246
Authors:
CREAVEN PJ
PEREZ R
PENDYALA L
MEROPOL NJ
LOEWEN G
LEVINE E
BERGHORN E
RAGHAVAN D
Citation: Pj. Creaven et al., UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY, Investigational new drugs, 15(3), 1997, pp. 227-234
Authors:
MEROPOL NJ
PORTER M
BLUMENSON LE
LINDEMANN MJ
PEREZ RP
VAICKUS L
LOEWEN GM
CREAVEN PJ
WILKES KA
GIEDLIN MA
CALIGIURI MA
Citation: Nj. Meropol et al., DAILY SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 EXPANDS NATURAL-KILLER-CELLS IN-VIVO WITHOUT SIGNIFICANT TOXICITY, Clinical cancer research, 2(4), 1996, pp. 669-677
Authors:
NORTH JH
WEBER TK
RODRIGUEZBIGAS MA
MEROPOL NJ
PETRELLI NJ
Citation: Jh. North et al., THE MANAGEMENT OF INFECTIOUS AND NONINFECTIOUS ANORECTAL COMPLICATIONS IN PATIENTS WITH LEUKEMIA, Journal of the American College of Surgeons, 183(4), 1996, pp. 322-328
Authors:
CUNNINGHAM D
ZALCBERG J
SMITH I
GORE M
PAZDUR R
BURRIS H
MEROPOL NJ
KENNEALEY G
SEYMOUR L
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - A NOVEL THYMIDYLATE SYNTHASE INHIBITOR WITH CLINICAL ANTITUMOR-ACTIVITY IN A RANGE OF SOLID TUMORS, Annals of oncology, 7(2), 1996, pp. 179-182
Authors:
MEROPOL NJ
RUSTUM YM
PETRELLI NJ
RODRIGUEZBIGAS M
FRANK C
HO DH
KUROWSKI M
CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ORAL URACIL, FTORAFUR, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 581-586
Authors:
SONI N
MEROPOL NJ
PORTER M
CALIGIURI MA
Citation: N. Soni et al., DIABETES-MELLITUS INDUCED BY LOW-DOSE INTERLEUKIN-2, Cancer immunology and immunotherapy, 43(1), 1996, pp. 59-62
Authors:
MEROPOL NJ
PAZDUR R
VINCENT M
WILLSON JKV
KELSEN DP
DOUGLASS HO
Citation: Nj. Meropol et al., PHASE-II STUDY OF ZD-1694 IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 19(6), 1996, pp. 628-630
Authors:
VAUGHN DJ
MEROPOL NJ
ARMSTEAD B
HALLER DG
Citation: Dj. Vaughn et al., A PILOT TRIAL OF 5-FU, LEUCOVORIN, AND CISPLATIN WITH OR WITHOUT ADRIAMYCIN IN ADVANCED CANCER, American journal of clinical oncology, 19(3), 1996, pp. 241-244
Authors:
CREAVEN PJ
RAGHAVAN D
PEREZ RP
PENDYALA L
BERGHORN EJ
LOEWEN G
MEROPOL NJ
Citation: Pj. Creaven et al., EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/, Seminars in oncology, 23(6), 1996, pp. 26-31
Authors:
RODRIGUEZBIGAS MA
KLIPPENSTEIN D
MEROPOL NJ
WEBER TK
PETRELLI NJ
Citation: Ma. Rodriguezbigas et al., A PILOT-STUDY OF CRYOCHEMOTHERAPY FOR HEPATIC METASTASES FROM COLORECTAL-CANCER, Cryobiology, 33(6), 1996, pp. 600-606
Authors:
MEROPOL NJ
PETRELLI NJ
LIPMAN BJ
RODRIGUEZBIGAS M
HICKS W
DOUGLASS HO
SMITH JL
RASEY M
BLUMENSON LE
VAICKUS L
HAYES FA
AGOSTI JM
Citation: Nj. Meropol et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY, The American journal of surgery, 172(3), 1996, pp. 299-302
Authors:
MEROPOL NJ
CREAVEN PJ
PETRELLI NJ
WHITE RM
ARBUCK SG
Citation: Nj. Meropol et al., SEIZURES ASSOCIATED WITH LEUCOVORIN ADMINISTRATION IN CANCER-PATIENTS, Journal of the National Cancer Institute, 87(1), 1995, pp. 56-58
Authors:
PAZDUR R
MEROPOL NJ
CASPER ES
FUCHS C
DOUGLASS HO
VINCENT M
ABBRUZZESE JL
Citation: R. Pazdur et al., PHASE-II TRIAL OF ZD1694 (TOMUDEX(TM)) IN PATIENTS WITH ADVANCED PANCREATIC-CANCER, Investigational new drugs, 13(4), 1995, pp. 355-358
Authors:
MEROPOL NJ
PETRELLI NJ
RUSTUM YM
RODRIQUEZBIGAS M
BLUMENSON LE
FRANK C
BERGHORN E
CREAVEN PJ
Citation: Nj. Meropol et al., A PHASE-II AND PHARMACOKINETIC STUDY OF 6S-LEUCOVORIN PLUS 5-FLUOROURACIL IN PATIENTS WITH COLORECTAL-CARCINOMA, Investigational new drugs, 13(2), 1995, pp. 149-155
Authors:
MEROPOL NJ
CREAVEN PJ
PETRELLI NJ
Citation: Nj. Meropol et al., METASTATIC COLORECTAL-CANCER - ADVANCES IN BIOCHEMICAL MODULATION ANDNEW DRUG DEVELOPMENT, Seminars in oncology, 22(5), 1995, pp. 509-524
Authors:
STEIN BN
PETRELLI NJ
DOUGLASS HO
DRISCOLL DL
ARCANGELI G
MEROPOL NJ
Citation: Bn. Stein et al., AGE AND SEX ARE INDEPENDENT PREDICTORS OF 5-FLUOROURASIL TOXICITY - ANALYSIS OF A LARGE-SCALE PHASE-III TRIAL, Cancer, 75(1), 1995, pp. 11-17